Ventas, Inc.·4

Apr 3, 4:05 PM ET

LUSTIG MATTHEW J 4

4 · Ventas, Inc. · Filed Apr 3, 2026

Research Summary

AI-generated summary of this filing

Updated

Ventas (VTR) Director Matthew J. Lustig Receives 396-Share Award

What Happened

  • Matthew J. Lustig, a director of Ventas, Inc. (VTR), was granted 396.293 shares on April 1, 2026. The shares are valued at $82.01 each (closing price on the grant date), for a total award value of $32,500. This was an award (grant) under the company's director compensation deferral program, not an open-market purchase.

Key Details

  • Transaction date: 2026-04-01; filing date: 2026-04-03 (appears timely; no late filing indicated).
  • Transaction type: A (award/grant).
  • Shares granted: 396.293 at $82.01 per share = $32,500 total (per filing).
  • Shares owned after transaction: Not specified in the provided filing.
  • Footnotes:
    • The shares were granted as units under the Ventas Non-Employee Directors' Cash Compensation Deferral Plan in lieu of director fees; units are payable solely in common stock and subject to the director's deferral election and plan terms.
    • $82.01 represents the issuer's closing price per share on the grant date.

Context

  • This is routine director compensation converted into company stock under a deferral plan and should not be read as an open-market bullish purchase. Such awards are common for non-employee directors and primarily reflect compensation decisions rather than direct trading sentiment.

Insider Transaction Report

Form 4
Period: 2026-04-01
Transactions
  • Award

    Common Stock

    [F1][F2]
    2026-04-01$82.01/sh+396.293$32,50092,662.739 total
Footnotes (2)
  • [F1]Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan.
  • [F2]Represents the closing price per share of Issuer's common stock as of the grant date.
Signature
Matthew J. Lustig, By: /s/ Jessica Stricklin, Attorney-In-Fact|2026-04-03

Documents

1 file
  • 4
    wk-form4_1775246703.xmlPrimary

    FORM 4